NEW YORK (GenomeWeb) – Agilent Technologies announced today that it has agreed to acquire Belgium-based molecular diagnostics developer Multiplicom for €68 million ($70.6 million) in cash.

The deal is expected to close in mid-January. All 90 Multiplicom employees will be offered jobs within Agilent, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.